Sponsor or institution
Clinical trials and research at Ontario Clinical Oncology Group (OCOG)
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Ontario Clinical Oncology Group (OCOG) that are recruiting, at sites in 2 countries (most in Canada (4), Australia (2)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Recurrence-directed therapy with or without 12 months of androgen-deprivation (ELIGARD) for radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer | Phase 2 | Hamilton, Ontario and 4 other locations | Recruiting | Oct 23, 2024 |
| Outpatient treatment with elranatamab for relapsed multiple myeloma | Phase 2 | Vancouver, British Columbia and 5 other locations | Recruiting | May 20, 2024 |
| Omitting radiation therapy for certain breast cancer patients after surgery | — | Cudgen, Cudgen and 26 other locations | Recruiting | May 19, 2023 |
| Comparing two types of breast radiation therapy after surgery | Phase 3 | Darlinghurst, New South Wales and 30 other locations | Recruiting | Jun 14, 2022 |
All recruiting trials (4)
-
Recurrence-directed therapy with or without 12 months of androgen-deprivation (ELIGARD) for radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer
This will test whether adding 12 months of ELIGARD® (androgen-deprivation therapy) to recurrence-directed radiotherapy helps men with radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer stay progression-free longer.
-
Outpatient treatment with elranatamab for relapsed multiple myeloma
This study is testing a new treatment called elranatamab for people with relapsed multiple myeloma to see if it can be safely given at home and help improve their health without needing to stay in the hospital.
-
Omitting radiation therapy for certain breast cancer patients after surgery
This study is testing if women with certain types of breast cancer who have no signs of cancer after treatment can skip radiation therapy after surgery and still do well.
-
Comparing two types of breast radiation therapy after surgery
This study is testing whether partial breast radiation or whole breast radiation works better for women with small, node-negative breast cancer after surgery.
Quick answers
How many clinical trials run by Ontario Clinical Oncology Group (OCOG) are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Canada (4 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.